Grace Kim Austin, MD
Otolaryngology · Valencia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 16 years
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2010
Offices
3 locations · Providence Facey Medical Foundation · Geoffrey Trenkle DO A Professional Medical Corporation
Hospitals listed: Providence Holy Cross Medical Center · Providence Saint Joseph Medical Ctr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Austin’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A145433 · Current
Licensed to practise in California · since 2016 · expires 2028-06-30 · Umdnj Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Plastic Surgery Within the Head and Neck
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Holy Cross Medical CenterMission Hills, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
- Providence Saint Joseph Medical CtrBurbank, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.302, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Holy Cross Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.05 to 1.9) · 1,299 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.62 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.53 (119.32 to 217.74) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 496 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 297 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 2,960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.01 to 0.42) · 5,542 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,701 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.08 (1.02 to 5.14) · 1,284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0 to 3.05) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.92 (0.45 to 3.4) · 1,235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (4.38 to 18.11) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.75 (2.09 to 9.41) · 353 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.44) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 0.91) · 4,791 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 166 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.258 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.091 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.947 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.638 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.691 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 196 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 948 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -36.2 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.1 · 626 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 10.5 · 315 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 548 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 8.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.2 to 15) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.7 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.3 · 104 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.5) · 218 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (0.9 to 1.7) · 119 cases | No different | Jan 2024 – Dec 2024 |
What patients said (439 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Providence Saint Joseph Medical Ctr
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.302 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.22 to 2.03) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.65 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.49 (127.09 to 219.89) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 762 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 405 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,463 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 9,525 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.42) · 9,594 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.44 (0.5 to 4.38) · 1,747 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.94 (0.29 to 3.59) · 501 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.69 to 3.63) · 1,665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.32 (3.85 to 18.79) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.39 (3.65 to 11.13) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.22 (0 to 0.75) · 8,013 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 100 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.533 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.247 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.227 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 278 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 610 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.7 · 254 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 42.8 · 640 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.4 · 825 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.3 to 6.8) · 211 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.6 to 17.3) · 211 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.8 to 16.9) · 463 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 508 cases | No different | Jan 2024 – Dec 2024 |
What patients said (360 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$32,766
Medicare paid this office $32,766 for 96 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 46 | $5,175 | $74 |
| New patient visit (45+ min) | 30 | $3,912 | $130 |
| Return visit (30+ min) | 27 | $3,744 | $101 |
| Removal of impacted ear wax | 23 | $1,224 | $38 |
| New patient visit (30+ min) | 14 | $1,052 | $75 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | – | – | – | 18 | 21 | 32 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | – | 14 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
96 Original Medicare patients in 2024. Average age 73 · Women 58% · Also on Medicaid 27% · Health risk score 1.32. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Coronary heart disease 31% · Depression 28% · Chronic kidney disease 27% · Diabetes 24% · Heart failure 20% · Atrial fibrillation 16% · Cancer 15% · COPD 15%.
The office billed $128,188, Medicare allowed $42,975 and paid $32,766; for 286 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 96 | 286 | 73 | 1.32 | $128,188 | $32,766 |
| 2023 | 68 | 187 | 74 | 1.19 | $77,701 | $21,136 |
| 2022 | 51 | 141 | 74 | 0.85 | $62,247 | $18,212 |
| 2021 | 68 | 183 | 73 | 1.14 | $81,519 | $21,959 |
| 2020 | 47 | 119 | 72 | 1.13 | $55,670 | $14,065 |
| 2019 | 60 | 155 | 72 | 1.28 | $68,889 | $18,192 |
| 2018 | 27 | 48 | 75 | 1.12 | $12,839 | $4,220 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 32 | $2,999 | $68 |
| Return visit (30+ min) | 25 | $2,942 | $105 |
| New patient visit (45+ min) | 23 | $2,786 | $121 |
| Removal of impacted ear wax | 14 | $870 | $41 |
2022: 4 services
| Short return visit (20+ min) | 21 | $2,332 | $69 |
| New patient visit (30+ min) | 22 | $2,146 | $98 |
| Return visit (30+ min) | 17 | $1,973 | $110 |
| Removal of impacted ear wax | 12 | $735 | $41 |
2021: 4 services
| Short return visit (20+ min) | 34 | $3,542 | $75 |
| New patient visit (30+ min) | 35 | $3,290 | $94 |
| Return visit (30+ min) | 14 | $1,575 | $113 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $1,419 | $101 |
2020: 2 services
| Short return visit (20+ min) | 30 | $2,490 | $57 |
| New patient visit (30+ min) | 11 | $1,069 | $97 |
2019: 3 services
| Short return visit (20+ min) | 34 | $2,946 | $61 |
| New patient visit (30+ min) | 23 | $2,107 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 12 | $1,923 | $101 |
Drugs they prescribed that Part D paid
$4,205
Pharmacies billed $4,205 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (13 of 296) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
294 generic and fewer than 11 brand-name prescriptions · $4,205 in drug cost · 63 antibiotic prescriptions to 53 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 12 | $777 | $19 |
| Azelastine | 13 | $683 | $24 |
| Fluticasone Propionate | 28 | $672 | $12 |
| Omeprazole | 19 | $330 | $8 |
| Ofloxacin | 12 | $276 | $20 |
See all 6 drugs
| Ipratropium | 12 | $777 | $19 |
| Azelastine | 13 | $683 | $24 |
| Fluticasone Propionate | 28 | $672 | $12 |
| Omeprazole | 19 | $330 | $8 |
| Ofloxacin | 12 | $276 | $20 |
| Cephalexin | 28 | $76 | $2 |
Year by year
| 2024 | 296 | 130 | 4% (13) | None | $4,205 |
| 2023 | 292 | 138 | None | None | $6,375 |
| 2022 | 266 | 116 | 8% (22) | 5% | $6,395 |
| 2021 | 257 | 110 | 7% (18) | 7% | $7,462 |
| 2020 | 113 | 59 | None | None | $3,391 |
| 2019 | 195 | 73 | 7% (13) | 7% | $4,654 |
| 2018 | 112 | 56 | None | None | $2,353 |
| 2017 | 33 | 18 | None | None | $1,339 |
| 2016 | 114 | 52 | 20% (23) | 10% | $2,477 |
| 2015 | 95 | 44 | 18% (17) | None | $3,171 |
| 2014 | 148 | 66 | 22% (32) | 19% | $7,797 |
| 2013 | 52 | 26 | 21% (11) | None | $3,513 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ipratropium | 39 | $1,295 | $33 |
| Azelastine | 35 | $955 | $27 |
| Fluticasone Propionate | 70 | $731 | $10 |
| Omeprazole | 18 | $197 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $148 | $11 |
| Cephalexin | 27 | $98 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $48 | $3 |
2022: 9 drugs
| Ofloxacin | 15 | $966 | $64 |
| Azelastine | 32 | $829 | $26 |
| Fluticasone Propionate | 39 | $502 | $13 |
| Ondansetron Odt | 20 | $230 | $11 |
| Omeprazole | 16 | $147 | $9 |
| Cephalexin | 34 | $121 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $78 | $7 |
| Hydrocodone-Acetaminophen | 15 | $66 | $4 |
| Sulfamethoxazole-Trimethoprim | 17 | $40 | $2 |
2021: 10 drugs
| Ciprofloxacin-Dexamethasone | 12 | $1,900 | $158 |
| Ofloxacin | 16 | $1,373 | $86 |
| Fluticasone Propionate | 35 | $622 | $18 |
| Nystatin | 15 | $463 | $31 |
| Azelastine | 12 | $388 | $32 |
| Ipratropium | 13 | $382 | $29 |
| Omeprazole | 26 | $334 | $13 |
| Ondansetron Odt | 16 | $151 | $9 |
| Cephalexin | 39 | $116 | $3 |
| Hydrocodone-Acetaminophen | 11 | $46 | $4 |
2020: 2 drugs
| Ofloxacin | 13 | $585 | $45 |
| Fluticasone Propionate | 12 | $141 | $12 |
2019: 4 drugs
| Ofloxacin | 11 | $765 | $70 |
| Ranitidine | 53 | $297 | $6 |
| Omeprazole | 31 | $175 | $6 |
| Cephalexin | 26 | $84 | $3 |
2018: 2 drugs
| Omeprazole | 14 | $95 | $7 |
| Ranitidine | 19 | $79 | $4 |
2016: 3 drugs
| Oxycodone | 13 | $124 | $10 |
| Cephalexin | 15 | $109 | $7 |
| Omeprazole | 15 | $51 | $3 |
2014: 2 drugs
| Oxycodone | 13 | $950 | $73 |
| Oxycodone-Acetaminophen | 16 | $185 | $12 |
Money from drug and device companies
$17 in 2022
| 2022 | 1 | 1 | None | $17 |
| 2021 | 3 | 3 | None | $192 |
| 2019 | 1 | 3 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Propel | $17 | 1 payment
|
See the published payment
| Medtronic | Meals · 2022-08-12 | Propel | $17 |
See earlier years (2021, 2019)
2021: $192
| Stryker | Xpress Ent Dilation System | $162 | 1 payment
|
| Galderma Laboratories L.P. | None | $18 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $13 | 1 payment
|
2019: $56
| Galderma Laboratories L.P. | None | $56 | 3 payments
|
Professional record
- NPI
- 1295052124
- Licence
- CA A145433, NC 164582California A145433: Current · expires 2028-06-30
- Trained
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2010 · 16 years ago
- Group
- Providence Facey Medical Foundation · Geoffrey Trenkle DO A Professional Medical Corporation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X); Federal specialty code 207YX0007X (207YX0007X); Student in a training program (390200000X)
- Mailing address
- Po Box 9602, Mission Hills, CA, 91346
- NPI first listed
- 2010-05-03
- NPI last updated
- 2026-02-02
- NPI record certified
- 2026-02-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 501 S Buena Vista St, Burbank, CA, 91505 · 800 Fairmount Ave Ste 411, Pasadena, CA, 91105